EAM
RLAY icon

Erste Asset Management’s Relay Therapeutics RLAY Stock Holding History

Erste Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$456K Hold
23,100
– – ﹤0.01% 524
2026
Q1 		$216K Hold
23,100
– – ﹤0.01% 562
2025
Q4 		$194K Hold
23,100
– – ﹤0.01% 550
2025
Q3 		$120K Hold
23,100
– – ﹤0.01% 576
2025
Q2 		$76.2K Hold
23,100
– – ﹤0.01% 838
2025
Q1 		$62.8K Hold
23,100
– – ﹤0.01% 505
2024
Q4 		$101K Hold
23,100
– – ﹤0.01% 502
2024
Q3 		$172K Hold
23,100
– – ﹤0.01% 485
2024
Q2 		$146K Hold
23,100
– – ﹤0.01% 486
2024
Q1 		$188K Hold
23,100
– – ﹤0.01% 476
2023
Q4 		$262K Hold
23,100
– – ﹤0.01% 470
2023
Q3 		$190K Hold
23,100
– – ﹤0.01% 481
2023
Q2 		$296K Hold
23,100
– – 0.01% 462
2023
Q1 		$368K Hold
23,100
– – 0.01% 453
2022
Q4 		$342K Hold
23,100
– – 0.01% 451
2022
Q3 		$535K Hold
23,100
– – 0.01% 416
2022
Q2 		$388K Hold
23,100
– – 0.01% 453
2022
Q1 		$708K Hold
23,100
– – 0.01% 397
2021
Q4 		$697K Hold
23,100
– – 0.01% 393
2021
Q3 		$771K Hold
23,100
– – 0.02% 360
2021
Q2 		$862K Hold
23,100
– – 0.02% 358
2021
Q1 		$822K Hold
23,100
– – 0.02% 344
2020
Q4 		$980K Buy
+23,100
New +$1.04M 0.03% 336

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Erste Asset Management's RLAY Position: Q2 2026 in Review

Erste Asset Management held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 23,100 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #524.

Erste Asset Management first reported a position in RLAY in Q4 2020 and has held it in 23 quarters since. The position peaked at $980K in Q4 2020. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Erste Asset Management held 23,100 shares of Relay Therapeutics worth $456K as of Q2 2026.
  • Erste Asset Management left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #524 holding.
  • Erste Asset Management first reported a position in Relay Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Erste Asset Management's Relay Therapeutics position peaked at $980K in Q4 2020.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.